Letters NICE on dementia

Omitting donepezil is hardly a hardship

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39388.433137.1F (Published 08 November 2007) Cite this as: BMJ 2007;335:954
  1. Thomas E Finucane, professor of medicine
  1. Johns Hopkins University School of Medicine, Burton Pavilion, 5505 Hopkins Bayview Circle, Baltimore, MD 21224, USA
  1. tfinucan{at}jhmi.edu

    To condemn the National Institute for Health and Clinical Excellence (NICE) as ageist when it limits access to donepezil is to …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe